Cancer

Items 1311-1320 of 2141

per page
Set Descending Direction
  1. Erlotinib hydrochloride
    CAS  183319-69-9
    SYN-1039
    SYN-1039-M0011 mg
    CHF 71.00
    SYN-1039-M0055 mg
    CHF 99.00
    SYN-1039-M01010 mg
    CHF 128.00
    SYN-1039-M05050 mg
    CHF 170.00
    SYN-1039-M100100 mg
    CHF 206.00
    Erlotinib hydrochloride
  2. Etoposide
    CAS  33419-42-0
    AG-CR1-3572
    AG-CR1-3572-M02525 mg
    CHF 30.00
    AG-CR1-3572-M100100 mg
    CHF 70.00
    AG-CR1-3572-51005 x 100 mg
    CHF 280.00
    Etoposide
  3. Euphol
    CAS  514-47-6
    AG-CN2-0541
    AG-CN2-0541-M0011 mg
    CHF 70.00
    AG-CN2-0541-M0055 mg
    CHF 210.00
    AG-CN2-0541-M02525 mg
    CHF 560.00
    Euphol
  4. Everolimus
    CAS  159351-69-6
    CDX-E0074
    CDX-E0074-M100100 mg
    CHF 530.00
    CDX-E0074-M250250 mg
    CHF 1'017.00
    Everolimus
  5. Everolimus
    CAS  159351-69-6
    AG-CN2-0520
    AG-CN2-0520-M0011 mg
    CHF 40.00
    AG-CN2-0520-M0055 mg
    CHF 75.00
    AG-CN2-0520-M02525 mg
    CHF 195.00
    Everolimus
  6. Everolimus Solution
    CAS  159351-69-6
    CDX-E0574
    CDX-E0574-M0011 ml
    CHF 204.00
    Everolimus Solution
  7. Famotidine
    CAS  76824-35-6
    AG-CR1-3730
    AG-CR1-3730-G0011 g
    CHF 40.00
    AG-CR1-3730-G0055 g
    CHF 120.00
    Famotidine
  8. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  9. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  10. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00

Items 1311-1320 of 2141

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.